Logotype for Century Therapeutics Inc

Century Therapeutics (IPSC) investor relations material

Century Therapeutics Piper Sandler 37th Annual Healthcare Conference summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Century Therapeutics Inc
Piper Sandler 37th Annual Healthcare Conference summary3 Dec, 2025

Key program updates and pipeline progress

  • Advancing iPSC-derived cell therapies, including CAR T, CAR NK, and beta islet cells for autoimmune diseases, cancer, and type 1 diabetes.

  • Beta islet cell program (CNTY813) aims to treat type 1 diabetes with reduced or no chronic immunosuppression, targeting IND-enabling studies by year-end and IND submission as early as next year.

  • CD19 CAR-iT (CNTY-308) is set to enter clinical trials next year, focusing initially on autoimmune diseases with potential for reduced or no lymphodepletion.

  • Phase 1 Carmel study of CD19 CAR-NK (CNTY-101) in multiple autoimmune diseases is ongoing, with initial safety and translational data expected at an upcoming conference.

  • Discontinued Calypso study to focus resources on more promising programs and partnerships.

Scientific and technological innovations

  • Alloevasion 5.0 platform enables iPSC-derived cells to evade both cellular and humoral immune responses, using unique edits such as a universal NK cell inhibitory ligand and an IgG-degrading protease.

  • Preclinical studies show the IgG-degrading protease effectively eliminates antibody-mediated immune attack without systemic IgG depletion.

  • iPSC cell foundry allows direct differentiation into various cell types, supporting scalable and reproducible manufacturing.

Strategic focus and future directions

  • Emphasis on scalable manufacturing to address large patient populations in autoimmune diseases and type 1 diabetes.

  • Ongoing and potential future partnerships with pharma to expand access and leverage Alloevasion technology in new fields.

  • Exploring regenerative medicine applications beyond immune cell types, such as dopaminergic neurons for Parkinson’s and heart muscle cells for cardiac disease.

Detail Alloevasion's unique IgG degrading protease
How does CNTY813 aim to reduce immunosuppression?
How will 308 address autoimmune disease scale?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Century Therapeutics earnings date

Logotype for Century Therapeutics Inc
Q4 202513 Mar, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Century Therapeutics earnings date

Logotype for Century Therapeutics Inc
Q4 202513 Mar, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Century Therapeutics Inc. is a biotechnology company focused on developing innovative cell therapy products. The company specializes in the creation of allogeneic cell therapies derived from induced pluripotent stem cells (iPSCs). These therapies are designed to treat a range of conditions, including solid tumors and hematological malignancies. Century Therapeutics' leading product candidates include therapies targeting specific cancer markers, such as CD19 and Nectin-4, and are developed through advanced gene editing and cellular engineering technologies. The company is headquartered in Philadelphia, Pennsylvania, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage